Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-κB signalling cascades

Digicaylioglu, M. et al. Localization of specific erythropoietin binding sites in defined areas of the mouse brain. Proc. Natl Acad. Sci. USA 92, 3717–3720 (1995).

Masuda, S. et al. Functional erythropoietin receptors of the cells with neuronal characteristics—comparison with receptor properties from erythroid cells. J. Biol. Chem. 268, 11208–11216 (1993).

Bernaudin, M. et al. Neurons and astrocytes express EPO mRNA: oxygen-sensing mechanisms that involve the redox-state of the brain. Glia 30, 271–278 (2000).

Morishita, E., Masuda, S., Nagao, M. & Sasaki, R. Erythropoietin receptor is expressed in rat hippocampal cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience 76, 105–116 (1997).

Sirén, A.-L. et al. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc. Natl Acad. Sci. USA 98, 4044–4049 (2001).

Anagnostou, A., Lee, E. S., Kessimian, N., Levinson, R. & Steiner, M. Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. Proc. Natl Acad. Sci. USA 87, 5978–5982 (1990).

Parganas, E. et al. Jak2 is essential for signaling through a variety of cytokine receptors. Cell 93, 385–395 (1998).

Lipton, S. A. et al. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 364, 626–632 (1993).

Dawson, V. L., Dawson, T. M., Bartley, D. A., Uhl, G. R. & Snyder, S. H. Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J. Neurosci. 13, 2651–2661 (1993).

Bonfoco, E., Krainc, D., Ankarcrona, M., Nicotera, P. & Lipton, S. A. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-d-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc. Natl Acad. Sci. USA 92, 7162–7166 (1995).

Gregory, T. et al. GATA-1 and erythropoietin cooperate to promote erythroid cell survival by regulating bcl-xL expression. Blood 94, 87–96 (1999).

Bonfoco, E. et al. Bcl-2 delays apoptosis and PARP cleavage induced by NO donors in GT1-7 cells. Neuroreport 8, 273–276 (1996).

Beg, A. A. & Baltimore, D. An essential role for NF-κB in preventing TNF-α-induced cell death. Science 274, 782–784 (1996).

Wang, C. Y., Mayo, M. W. & Baldwin, A. S. Jr TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science 274, 784–787 (1996).

Van Antwerp, D. J., Martin, S. J., Kafri, T., Green, D. R. & Verma, I. M. Suppression of TNF-α-induced apoptosis by NF-κB. Science 274, 787–789 (1996).

Grilli, M., Pizzi, M., Memo, M. & Spano, P. Neuroprotection by aspirin and sodium salicylate through blockade of NF-κB activation. Science 274, 1383–1385 (1996).

Wang, C. Y., Mayo, M. W., Korneluk, R. G., Goeddel, D. V. & Baldwin, A. S. Jr NF-κB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281, 1680–1683 (1998).

O'Neill, L. A. & Kaltschmidt, C. NF-κB: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci. 20, 252–258 (1997).

Mattson, M. P., Goodman, Y., Luo, H., Fu, W. & Furukawa, K. Activation of NF-κB protects hippocampal neurons against oxidative stress-induced apoptosis: evidence for induction of manganese superoxide dismutase and suppression of peroxynitrite production and protein tyrosine nitration. J. Neurosci. Res. 49, 681–697 (1997).

Schreck, R., Meier, B., Mannel, D. N., Droge, W. & Baeuerle, P. A. Dithiocarbamates as potent inhibitors of nuclear factor κB activation in intact cells. J. Exp. Med. 175, 1181–1194 (1992).

Lin, Y. Z., Yao, S. Y., Veach, R. A., Torgerson, T. R. & Hawiger, J. Inhibition of nuclear translocation of transcription factor NF-κB by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. J. Biol. Chem. 270, 14255–14258 (1995).

Iimuro, Y. et al. NF-κB prevents apoptosis and liver dysfunction during liver regeneration. J. Clin. Invest. 101, 802–811 (1998).

Lezoualc’h, F., Sagara, Y., Holsboer, F. & Behl, C. High constitutive NF-κB activity mediates resistance to oxidative stress in neuronal cells. J. Neurosci. 18, 3224–3232 (1998).

Ihle, J. N., Witthuhn, B. A., Quelle, F. W., Yamamoto, K. & Silvennoinen, O. Signaling through the hematopoietic cytokine receptors. Annu. Rev. Immunol. 13, 369–398 (1995).

Meydan, N. et al. Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature 379, 645–648 (1996).

Briscoe, J. et al. Kinase-negative mutants of JAK1 can sustain interferon-gamma-inducible gene expression but not an antiviral state. EMBO J. 15, 799–809 (1996).

Zhuang, H. et al. Inhibition of erythropoietin-induced mitogenesis by a kinase-deficient form of Jak2. J. Biol. Chem. 269, 21411–21414 (1994).

Gage, A. T. & Stanton, P. K. Hypoxia triggers neuroprotective alterations in hippocampal gene expression via a heme-containing sensor. Brain Res. 719, 172–178 (1996).

Schmidt, H. H. H. W. & Kelm, M. in Methods in Nitric Oxide Research (eds Feelisch, M. & Stamler, J. S.) 491–497 (Wiley, Chichester, 1996).

Imbert, V. et al. Tyrosine phosphorylation of IκB-α activates NF-κB without proteolytic degradation of IκB-α. Cell 86, 787–798 (1996).